AstraZeneca ’s Vaccine Does Not Work Well Against Virus Variant in South Africa

The bad news, coming nearly a week after a million doses of the AstraZeneca-Oxford vaccine arrived in South Africa, was a big setback for the country.

Source: NYT Health - February 8, 2021 Category: Consumer Health News Authors: Benjamin Mueller, Rebecca Robbins and Lynsey Chutel Tags: AstraZeneca PLC Vaccination and Immunization Coronavirus (2019-nCoV) South Africa Clinical Trials your-feed-healthcare your-feed-science Source Type: news